Table 1.
Demographic and clinical characteristics of adults and children.
| Characteristics | Total All Families, n = 91 | p Value | |
|---|---|---|---|
| Adults, (n = 37) | Children, (n = 54) | ||
| Age (years), mean (SD) | 41.1 (11.4) | 8.7 (5.8) | NA |
| Gender, n (%) | 1.00 | ||
| Female | 24 (64.9) | 35 (64.8) | |
| Male | 13 (35.1) | 19 (35.2) | |
| Ethnicity, n (%) | 0.89 | ||
| Black | 18 (48.7) | 22 (40.7) | |
| White | 7 (18.9) | 18 (33.3) | |
| Arab/West Asian | 7 (18.9) | 8 (14.8) | |
| Other 1 | 5 (13.5) | 6 (11.1) | |
| Comorbidity present, n (%) | 18 (48.7) | 14 (25.9) | 0.06 |
| Immunodeficiency | 8 (21.6) | 3 (5.6) | 0.02 |
| Autoimmune disease | 4 (10.8) | 1 (1.9) | 0.12 |
| Obesity | 6 (16.2) | 1 (1.9) | 0.01 |
| Hypertension | 4 (10.8) | 0 (0.0) | 0.03 |
| Asthma | 3 (8.1) | 2 (3.7) | 0.51 |
| Neurologic disease | 0 (0.0) | 3 (5.6) | 0.22 |
| Other | 4 (10.8) | 5 (9.3) | 0.85 |
| SARS-CoV-2 symptoms | 0.31 | ||
| Asymptomatic | 5 (13.5) | 13 (24.1) | |
| Symptomatic | 32 (86.5) | 41 (75.9) | |
| Mild | 21 (56.8) | 38 (70.4) | 0.01 |
| Moderate | 6 (16.2) | 3 (5.6) | |
| Severe/Critical | 5 (13.5) | 0 (0.0) | |
| SARS-CoV-2 serology testing | |||
| Seropositive (Ab titer ≥15 AU/mL) | 28 (75.7) | 50 (92.6) | 0.05 |
| Titer (AU/mL), median (IQR) | 79.8 (18.8–219.0) | 107.0 (51.8–164.0) | 0.36 |
1 Other includes Filipino and Latin American.